Myer expects 7 million per year saving from exiting 1 level of admin support..
1H expectation of net profit after tax of 37-41 Million pre implementation costs.
Sales online in 1H 2018 were up 48.9 percent, following a 48.4 percent increase in 1H 2017.
......
So by this it seems that online sales would be expected to continue rising for at least the next few years.
Id like to see more savings on the admin side, Id expect possibly some more savings in the next year as well.
7 Million savings in admin, is in some way equivalent to 10% of the 70m net profit (pre implement costs)
6% fall in sales, but partly offset by admin costs boosting net profit 10% , (ie 7m = 10% of 70m approx net profit pre costs)
At some point in the next year or 2 or so, there could be a half or full year that has a rise in total net profit off a low base.
By admin cost reductions and growth in online sales looking like being probable in the future.
Timeline for this possibly 2 years, and By then I would think some possible tax relief for middle income kicking in as well.
- Forums
- ASX - By Stock
- MYR
- Ann: Q2 Trading Update
Ann: Q2 Trading Update, page-362
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
80.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $665.4M |
Open | High | Low | Value | Volume |
80.5¢ | 80.5¢ | 78.5¢ | $1.043M | 1.307M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 95144 | 79.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 36476 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 96650 | 0.795 |
8 | 53930 | 0.790 |
8 | 55971 | 0.785 |
8 | 52364 | 0.780 |
7 | 125751 | 0.775 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 40825 | 8 |
0.805 | 43017 | 3 |
0.810 | 54839 | 5 |
0.815 | 126401 | 4 |
0.820 | 66133 | 12 |
Last trade - 15.41pm 15/07/2024 (20 minute delay) ? |
Featured News
MYR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online